terazosin



terazosin


SMILES COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)[nH]c(=N)c2cc1OC
InChIKey VCKUSRYTPJJLNI-UHFFFAOYSA-N

Chemical Properties

Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 4
Molecular weight (Da) 387.2

Database connections

Ligand site mutations α1A α1B

No bioactivity data available.

terazosin


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I
Phase II
Phase III
Phase IV

Database connections

Ligand site mutations α1A α1B

Compound is not listed as a drug.